Solace Pharmaceuticals Closes Boston-Area Office After Pain Treatment Fails in Clinical Trial
2/8/2010 7:13:05 AM
More...
|
Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board
7/27/2009 9:34:00 AM
More...
|
Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia
1/12/2009 8:57:48 AM
More...
|
UK Biotech Wargame Gains Support from Leading Companies in the Industry
7/8/2008 1:22:46 PM
More...
|
Solace Pharmaceuticals Names Two New Senior Team Members
1/30/2008 11:21:23 AM
More...
|
Molecule Discovered To Be Key To Pain Sensitivity
10/23/2006 1:46:29 PM
More...
|
Solace Pharmaceuticals Scientists Uncover Molecule Linked To Pain Sensitivity
10/23/2006 11:58:59 AM
More...
|